nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Trauma—Triamcinolone—multiple sclerosis	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Trauma—Methylprednisolone—multiple sclerosis	0.0114	0.0114	CcSEcCtD
Nalidixic Acid—Epilepsy—Prednisone—multiple sclerosis	0.0113	0.0113	CcSEcCtD
Nalidixic Acid—Trauma—Dexamethasone—multiple sclerosis	0.0104	0.0104	CcSEcCtD
Nalidixic Acid—Trauma—Betamethasone—multiple sclerosis	0.0104	0.0104	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisone—multiple sclerosis	0.0103	0.0103	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisolone—multiple sclerosis	0.00964	0.00964	CcSEcCtD
Nalidixic Acid—Trauma—Prednisone—multiple sclerosis	0.00905	0.00905	CcSEcCtD
Nalidixic Acid—Swelling—Cladribine—multiple sclerosis	0.00905	0.00905	CcSEcCtD
Nalidixic Acid—Optic neuritis—Triamcinolone—multiple sclerosis	0.00887	0.00887	CcSEcCtD
Nalidixic Acid—Optic neuritis—Methylprednisolone—multiple sclerosis	0.00885	0.00885	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00884	0.00884	CcSEcCtD
Nalidixic Acid—Blister—Prednisolone—multiple sclerosis	0.00823	0.00823	CcSEcCtD
Nalidixic Acid—Optic neuritis—Dexamethasone—multiple sclerosis	0.00805	0.00805	CcSEcCtD
Nalidixic Acid—Optic neuritis—Betamethasone—multiple sclerosis	0.00805	0.00805	CcSEcCtD
Nalidixic Acid—Leukopenia—Fingolimod—multiple sclerosis	0.00759	0.00759	CcSEcCtD
Nalidixic Acid—Blister—Triamcinolone—multiple sclerosis	0.00757	0.00757	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisone—multiple sclerosis	0.00701	0.00701	CcSEcCtD
Nalidixic Acid—Blister—Betamethasone—multiple sclerosis	0.00687	0.00687	CcSEcCtD
Nalidixic Acid—Blister—Dexamethasone—multiple sclerosis	0.00687	0.00687	CcSEcCtD
Nalidixic Acid—Eosinophilia—Cladribine—multiple sclerosis	0.00683	0.00683	CcSEcCtD
Nalidixic Acid—Paraesthesia—Fingolimod—multiple sclerosis	0.00622	0.00622	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.0061	0.0061	CcSEcCtD
Nalidixic Acid—Swelling—Mitoxantrone—multiple sclerosis	0.00595	0.00595	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00542	0.00542	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Cladribine—multiple sclerosis	0.00522	0.00522	CcSEcCtD
Nalidixic Acid—Asthenia—Fingolimod—multiple sclerosis	0.00497	0.00497	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00496	0.00496	CcSEcCtD
Nalidixic Acid—Pruritus—Fingolimod—multiple sclerosis	0.0049	0.0049	CcSEcCtD
Nalidixic Acid—Erythema—Cladribine—multiple sclerosis	0.00481	0.00481	CcSEcCtD
Nalidixic Acid—Diarrhoea—Fingolimod—multiple sclerosis	0.00474	0.00474	CcSEcCtD
Nalidixic Acid—Injury—Prednisolone—multiple sclerosis	0.00468	0.00468	CcSEcCtD
Nalidixic Acid—Dizziness—Fingolimod—multiple sclerosis	0.00458	0.00458	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Prednisolone—multiple sclerosis	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00445	0.00445	CcSEcCtD
Nalidixic Acid—Headache—Fingolimod—multiple sclerosis	0.00434	0.00434	CcSEcCtD
Nalidixic Acid—Injury—Triamcinolone—multiple sclerosis	0.00431	0.00431	CcSEcCtD
Nalidixic Acid—Injury—Methylprednisolone—multiple sclerosis	0.0043	0.0043	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Azathioprine—multiple sclerosis	0.00425	0.00425	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00414	0.00414	CcSEcCtD
Nalidixic Acid—Arthralgia—Cladribine—multiple sclerosis	0.00409	0.00409	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00409	0.00409	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00408	0.00408	CcSEcCtD
Nalidixic Acid—Drowsiness—Mitoxantrone—multiple sclerosis	0.00404	0.00404	CcSEcCtD
Nalidixic Acid—Injury—Betamethasone—multiple sclerosis	0.00391	0.00391	CcSEcCtD
Nalidixic Acid—Injury—Dexamethasone—multiple sclerosis	0.00391	0.00391	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00386	0.00386	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cladribine—multiple sclerosis	0.00384	0.00384	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00358	0.00358	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cladribine—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Betamethasone—multiple sclerosis	0.00351	0.00351	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00351	0.00351	CcSEcCtD
Nalidixic Acid—Leukopenia—Azathioprine—multiple sclerosis	0.0035	0.0035	CcSEcCtD
Nalidixic Acid—Somnolence—Cladribine—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Nalidixic Acid—Injury—Prednisone—multiple sclerosis	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Arthralgia—Azathioprine—multiple sclerosis	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00325	0.00325	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00321	0.00321	CcSEcCtD
Nalidixic Acid—Erythema—Mitoxantrone—multiple sclerosis	0.00316	0.00316	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Urticaria—Cladribine—multiple sclerosis	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Abdominal pain—Cladribine—multiple sclerosis	0.0031	0.0031	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Prednisone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00299	0.00299	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00298	0.00298	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Visual impairment—Prednisolone—multiple sclerosis	0.00287	0.00287	CcSEcCtD
Nalidixic Acid—Leukopenia—Mitoxantrone—multiple sclerosis	0.00283	0.00283	CcSEcCtD
Nalidixic Acid—Asthenia—Cladribine—multiple sclerosis	0.00282	0.00282	CcSEcCtD
Nalidixic Acid—Pruritus—Cladribine—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Nalidixic Acid—Convulsion—Mitoxantrone—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Arthralgia—Mitoxantrone—multiple sclerosis	0.00269	0.00269	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cladribine—multiple sclerosis	0.00268	0.00268	CcSEcCtD
Nalidixic Acid—Visual impairment—Methylprednisolone—multiple sclerosis	0.00263	0.00263	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00261	0.00261	CcSEcCtD
Nalidixic Acid—Dizziness—Cladribine—multiple sclerosis	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Erythema—Prednisolone—multiple sclerosis	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00258	0.00258	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00253	0.00253	CcSEcCtD
Nalidixic Acid—Abdominal pain—Azathioprine—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Nalidixic Acid—Vomiting—Cladribine—multiple sclerosis	0.0025	0.0025	CcSEcCtD
Nalidixic Acid—Rash—Cladribine—multiple sclerosis	0.00247	0.00247	CcSEcCtD
Nalidixic Acid—Dermatitis—Cladribine—multiple sclerosis	0.00247	0.00247	CcSEcCtD
Nalidixic Acid—Headache—Cladribine—multiple sclerosis	0.00246	0.00246	CcSEcCtD
Nalidixic Acid—Visual impairment—Betamethasone—multiple sclerosis	0.0024	0.0024	CcSEcCtD
Nalidixic Acid—Visual impairment—Dexamethasone—multiple sclerosis	0.0024	0.0024	CcSEcCtD
Nalidixic Acid—Erythema—Triamcinolone—multiple sclerosis	0.00238	0.00238	CcSEcCtD
Nalidixic Acid—Erythema—Methylprednisolone—multiple sclerosis	0.00238	0.00238	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisolone—multiple sclerosis	0.00237	0.00237	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00235	0.00235	CcSEcCtD
Nalidixic Acid—Nausea—Cladribine—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisolone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00232	0.00232	CcSEcCtD
Nalidixic Acid—Somnolence—Mitoxantrone—multiple sclerosis	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisolone—multiple sclerosis	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—multiple sclerosis	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Diarrhoea—Azathioprine—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Angioedema—Triamcinolone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Angioedema—Methylprednisolone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Nalidixic Acid—Erythema—Betamethasone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Erythema—Dexamethasone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Vertigo—Triamcinolone—multiple sclerosis	0.00214	0.00214	CcSEcCtD
Nalidixic Acid—Vertigo—Methylprednisolone—multiple sclerosis	0.00214	0.00214	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00212	0.00212	CcSEcCtD
Nalidixic Acid—Dizziness—Azathioprine—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Nalidixic Acid—Convulsion—Triamcinolone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Convulsion—Methylprednisolone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Urticaria—Mitoxantrone—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Nalidixic Acid—Vomiting—Azathioprine—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Nalidixic Acid—Arthralgia—Methylprednisolone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Rash—Azathioprine—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Dermatitis—Azathioprine—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Headache—Azathioprine—multiple sclerosis	0.002	0.002	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.002	0.002	CcSEcCtD
Nalidixic Acid—Angioedema—Dexamethasone—multiple sclerosis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Angioedema—Betamethasone—multiple sclerosis	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Nalidixic Acid—Vertigo—Dexamethasone—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Vertigo—Betamethasone—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisolone—multiple sclerosis	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Nausea—Azathioprine—multiple sclerosis	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Nalidixic Acid—Convulsion—Dexamethasone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Nalidixic Acid—Convulsion—Betamethasone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Nalidixic Acid—Asthenia—Mitoxantrone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Nalidixic Acid—Paraesthesia—Triamcinolone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisolone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Nalidixic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Rash—Mitoxantrone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Nalidixic Acid—Headache—Mitoxantrone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Nalidixic Acid—Arthralgia—Prednisone—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Nalidixic Acid—Paraesthesia—Betamethasone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Nalidixic Acid—Paraesthesia—Dexamethasone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Urticaria—Triamcinolone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Nalidixic Acid—Urticaria—Methylprednisolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Nalidixic Acid—Nausea—Mitoxantrone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Nalidixic Acid—Urticaria—Dexamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Urticaria—Betamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Asthenia—Triamcinolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Abdominal pain—Betamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Asthenia—Methylprednisolone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Nalidixic Acid—Pruritus—Triamcinolone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Nalidixic Acid—Pruritus—Methylprednisolone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Nalidixic Acid—Rash—Prednisolone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Nalidixic Acid—Headache—Prednisolone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Nalidixic Acid—Dizziness—Triamcinolone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Nalidixic Acid—Dizziness—Methylprednisolone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Asthenia—Betamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Nalidixic Acid—Asthenia—Dexamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Nausea—Prednisolone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Pruritus—Dexamethasone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Nalidixic Acid—Pruritus—Betamethasone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Nalidixic Acid—Vomiting—Triamcinolone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Nalidixic Acid—Vomiting—Methylprednisolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Nalidixic Acid—Rash—Triamcinolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Nalidixic Acid—Dermatitis—Triamcinolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Nalidixic Acid—Rash—Methylprednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Headache—Triamcinolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Headache—Methylprednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Abdominal pain—Prednisone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Diarrhoea—Betamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Dizziness—Dexamethasone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Dizziness—Betamethasone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Nausea—Triamcinolone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Nausea—Methylprednisolone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Nalidixic Acid—Vomiting—Betamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Nalidixic Acid—Vomiting—Dexamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Nalidixic Acid—Rash—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Rash—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Dermatitis—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Dermatitis—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Headache—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Headache—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Nausea—Dexamethasone—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Nausea—Betamethasone—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—multiple sclerosis	0.000978	0.000978	CcSEcCtD
Nalidixic Acid—Rash—Prednisone—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—multiple sclerosis	0.000969	0.000969	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—multiple sclerosis	0.000963	0.000963	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—multiple sclerosis	0.000922	0.000922	CcSEcCtD
Nalidixic Acid—Nausea—Prednisone—multiple sclerosis	0.000913	0.000913	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—multiple sclerosis	0.000909	0.000909	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—multiple sclerosis	0.000879	0.000879	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—multiple sclerosis	0.00085	0.00085	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—multiple sclerosis	0.000817	0.000817	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—multiple sclerosis	0.00081	0.00081	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—multiple sclerosis	0.00081	0.00081	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—multiple sclerosis	0.000805	0.000805	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—multiple sclerosis	0.000763	0.000763	CcSEcCtD
